Answers are grounded in this paper and cite their sources.
Case report reveals challenges in managing a rare ovarian tumor in elderly patients, emphasizing clinical complexities.
Poorly differentiated Sertoli-Leydig cell tumors of the ovary are exceptionally rare and often difficult to classify, frequently requiring expert pathology review. Their clinical course can be aggressive, and therapeutic decisions are particularly complex in older patients with comorbidities. We describe a woman in her seventies who presented with advanced disease and underwent extensive cytoreductive surgery, followed by systemic chemotherapy. Despite an initial partial response, she experienced disease progression with recurrent ascites and peritoneal carcinomatosis. This case illustrates the diagnostic pitfalls, the importance of multidisciplinary evaluation, and the therapeutic dilemmas encountered when standard regimens fail. It also underscores the need to balance oncological benefit with quality-of-life considerations in elderly patients with rare ovarian malignancies.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: